Jiménez-Montero Beatriz, Baquero-Artigao Fernando, Saavedra-Lozano Jesús, Tagarro-García Alfredo, Blázquez-Gamero Daniel, Cilleruelo-Ortega María J, Ramos-Amador José T, Galé-Ansó Inés, Marín Natalia, Gómez-García Raquel, Santiago-García Begoña, Garrido Jesus, López Goosen
From the *Department of Pediatrics, Hospital Infanta Sofía, San Sebastián de los Reyes; †Division of Pediatric Infectious Diseases, Hospital Universitario La Paz; ‡Division of Pediatric Infectious Diseases, Gregorio Marañón Hospital; §Division of Pediatric Infectious Diseases, Hospital Universitario 12 de Octubre; ¶Department of Pediatrics, Hospital Puerta de Hierro- Majadahonda; ‖Department of Pediatrics, Hospital de Getafe; and **Department of Microbiology, Hospital Universitario La Paz, Madrid.
Pediatr Infect Dis J. 2014 Jan;33(1):28-34. doi: 10.1097/INF.0000000000000007.
Mycobacterium lentiflavum is considered a rare pathogen causing nontuberculous mycobacterial (NTM) lymphadenitis.
A multicenter, retrospective study was performed in immunocompetent children <14 years of age with microbiologically confirmed NTM lymphadenitis treated at 6 hospitals in Madrid, Spain, during 2000-2010. We compared children with M. lentiflavum and Mycobacterium avium-intracellulare complex infection.
Forty-five microbiologically confirmed NTM lymphadenitis patients were identified: 19 (45.2%) caused by M. avium-intracellulare complex, 17 (40.5%) by M. lentiflavum, 1 by both and 5 by other mycobacteria. Out of 17 M. lentiflavum cases, 14 were diagnosed in the past 5 years. Regarding M. lentiflavum cases, median age was 23 months. Submandibular nodes were the most frequently involved (76.5%), with multiple locations seen in 41% of the children and spontaneous drainage in 41% of them. Drug susceptibility tests were performed in 14 isolates and showed a complete susceptibility to clarithromycin and cycloserine, whereas 93% were resistant to rifampin, 33% to quinolones and full resistance to other tested antimycobacterial drugs was detected. All but 1 child required surgery and 11 were treated additionally with various drug combinations. Total resolution was achieved in 50% of children within 6 months.Compared with M. avium-intracellulare complex cases, children were younger and laterocervical nodes were significantly less frequently involved. No statistically significant differences were found related to clinical characteristics, treatment and outcome.
M. lentiflavum is an emerging pathogen producing NTM lymphadenitis in Madrid.
淡黄分枝杆菌被认为是引起非结核分枝杆菌(NTM)淋巴结炎的一种罕见病原体。
对2000年至2010年期间在西班牙马德里的6家医院接受微生物学确诊的NTM淋巴结炎治疗的14岁以下免疫功能正常儿童进行了一项多中心回顾性研究。我们比较了感染淡黄分枝杆菌和鸟分枝杆菌复合群的儿童。
确定了45例微生物学确诊的NTM淋巴结炎患者:19例(45.2%)由鸟分枝杆菌复合群引起,17例(40.5%)由淡黄分枝杆菌引起,1例由两者共同引起,5例由其他分枝杆菌引起。在17例淡黄分枝杆菌病例中,14例在过去5年中被诊断出来。对于淡黄分枝杆菌病例,中位年龄为23个月。下颌下淋巴结是最常受累的部位(76.5%),41%的儿童有多个部位受累,41%的儿童出现自发引流。对14株分离菌进行了药敏试验,结果显示对克拉霉素和环丝氨酸完全敏感,而93%对利福平耐药,33%对喹诺酮类耐药,对其他测试的抗分枝杆菌药物检测到完全耐药。除1名儿童外,所有儿童均需要手术治疗,11名儿童还接受了各种药物联合治疗。50%的儿童在6个月内完全康复。与鸟分枝杆菌复合群病例相比,感染淡黄分枝杆菌的儿童年龄更小,颈外侧淋巴结受累明显较少。在临床特征、治疗和结局方面未发现统计学上的显著差异。
在马德里,淡黄分枝杆菌是引起NTM淋巴结炎的一种新兴病原体。